Hansa Biopharma plans restructuring to strengthen long-term competitiveness and advance key deliverables

As part of the restructuring, Hansa will notify the Swedish Public Employment Service (Sw. Arbetsförmedlingen) and seek consultations with the trade unions regarding the reorganisation. Decisions regarding employee reductions will take place after the change consultations have been concluded according to local regulations. As part of the restructuring, Hansa will notify the Swedish Public Employment Service (Sw.Arbetsförmedlingen ) and seek consultations with the trade unions regarding the...

As part of the restructuring, Hansa will notify the Swedish Public Employment Service (Sw. Arbetsförmedlingen) and seek consultations with the trade unions regarding the reorganisation. Decisions regarding employee reductions will take place after the change consultations have been concluded according to local regulations.

This is information that Hansa Biopharma AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact persons set out below, at 13:05 CET on December 5, 2023. 

For further information, please contact:

Klaus Sindahl, VP Head of Investor Relations
M: +46 (0) 709–298 269
E: klaus.sindahl@hansabiopharma.com

Stephanie Kenney, VP Global Corporate Affairs
M: +1 (484) 319 2802
E: stephanie.kenney@hansabiopharma.com

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/hansa-biopharma-plans-restructuring-to-strengthen-long-term-competitiveness-and-advance-key-deliverables-302005996.html